Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 9,682 DCOY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Decoy Therapeutics Inc. (DCOY) | Grant/Award | 9,682 | n/a |
| Nov 20, 2025 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase | 20,000 | $16.0K |
| Feb 22, 2024 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 22,500 | n/a |
| Feb 15, 2023 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 6,432 | n/a |
| Jan 5, 2023 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 8,000 | n/a |
| Nov 7, 2022 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 7,314 | $12.7K |
| May 31, 2022 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase | 28,000 | $5.0K |
| May 5, 2022 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 10,000 | $1.9K |
| Mar 9, 2022 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase | 76,246 | $29.8K |
| Jan 21, 2022 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/Award | 200,000 | n/a |